Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question.
Ordóñez-Reyes C, Garcia-Robledo JE, Chamorro DF, Mosquera A, Sussmann L, Ruiz-Patiño A, Arrieta O, Zatarain-Barrón L, Rojas L, Russo A, de Miguel-Perez D, Rolfo C, Cardona AF. Ordóñez-Reyes C, et al. Among authors: zatarain barron l. Pharmaceutics. 2022 Jun 11;14(6):1243. doi: 10.3390/pharmaceutics14061243. Pharmaceutics. 2022. PMID: 35745815 Free PMC article. Review.
KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.
Garcia-Robledo JE, Rosell R, Ruíz-Patiño A, Sotelo C, Arrieta O, Zatarain-Barrón L, Ordoñez C, Jaller E, Rojas L, Russo A, de Miguel-Pérez D, Rolfo C, Cardona AF. Garcia-Robledo JE, et al. Among authors: zatarain barron l. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666211066064. doi: 10.1177/17534666211066064. Ther Adv Respir Dis. 2022. PMID: 35098800 Free PMC article. Review.
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.
Cifuentes C, Lombana M, Vargas H, Laguado P, Ruiz-Patiño A, Rojas L, Navarro U, Vargas C, Ricaurte L, Arrieta O, Zatarain-Barron L, Zapata L, González G, Ortiz C, Bernal L, Restrepo JG, Viola L, Grosso F, Zapata R, Mantilla W, Carranza H, Bustillo I, Llinas N, Duarte R, Rodríguez J, Archila P, Ávila J, Bermúdez M, Gámez T, Sotelo C, Otero J, Forero E, Lema M, Limpias C, Ordóñez-Reyes C, Mejía S, Rolfo C, Rosell R, Cardona AF; ONCOL Group; CLICaP. Cifuentes C, et al. Among authors: zatarain barron l. Cancer Control. 2023 Jan-Dec;30:10732748231175256. doi: 10.1177/10732748231175256. Cancer Control. 2023. PMID: 37148308 Free PMC article.
Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomas.
Cañas A, Jiménez E, Hakim F, Mejía JA, Ramón JF, Gómez D, Jaramillo-Velásquez D, Bermúdez S, Useche N, Pineda D, Cifuentes H, Becerra A, Muñoz Á, Santoyo N, Ruíz-Patiño A, Sotelo C, Archila P, Rodríguez J, Ávila J, Ordoñez-Reyes C, García-Robledo JE, Ricaurte L, Rojas L, Feo O, Burgos R, Ramírez C, Arrieta O, Zatarain-Barrón L, Vargas C, Carranza H, Otero J, Cardona AF. Cañas A, et al. Among authors: zatarain barron l. Biomedica. 2022 Dec 1;42(4):574-590. doi: 10.7705/biomedica.6100. Biomedica. 2022. PMID: 36511679 Free PMC article. English, Spanish.
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics.
Ruiz-Patiño A, Rodríguez J, Cardona AF, Ávila J, Archila P, Carranza H, Vargas C, Otero J, Arrieta O, Zatarain-Barrón L, Sotelo C, Ordoñez C, García-Robledo JE, Rojas L, Bermúdez M, Gámez T, Mayorga D, Corrales L, Martín C, Recondo G, Mas L, Samtani S, Ricaurte L, Malapelle U, Russo A, Barrón F, Santoyo N, Rolfo C, Rosell R; ONCOLGroup; CLICaP. Ruiz-Patiño A, et al. Among authors: zatarain barron l. Transl Oncol. 2022 Jan;15(1):101276. doi: 10.1016/j.tranon.2021.101276. Epub 2021 Nov 22. Transl Oncol. 2022. PMID: 34823093 Free PMC article.
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
Cordeiro de Lima VC, Corassa M, Saldanha E, Freitas H, Arrieta O, Raez L, Samtani S, Ramos M, Rojas C, Burotto M, Chamorro DF, Recondo G, Ruiz-Patiño A, Más L, Zatarain-Barrón L, Mejía S, Nicolas Minata J, Martín C, Bautista Blaquier J, Motta Guerrero R, Aliaga-Macha C, Carracedo C, Ordóñez-Reyes C, Garcia-Robledo JE, Corrales L, Sotelo C, Ricaurte L, Santoyo N, Cuello M, Jaller E, Rodríguez J, Archila P, Bermudez M, Gamez T, Russo A, Viola L, Malapelle U, de Miguel Perez D, Rolfo C, Rosell R, Cardona AF. Cordeiro de Lima VC, et al. Among authors: zatarain barron l. Lung Cancer. 2022 Aug;170:114-121. doi: 10.1016/j.lungcan.2022.06.010. Epub 2022 Jun 20. Lung Cancer. 2022. PMID: 35753125 Free article.
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).
Cardona AF, Ordóñez-Reyes C, Ruiz-Patiño A, Garcia-Robledo JE, Barron LZ, Recondo G, Rojas L, Corrales L, Martín C, Barrón F, Sotelo C, Rodríguez J, Ricaurte L, Rolfo C, Ávila J, Mayorga D, Archila P, Otero J, Mas L, Bermudez M, Gamez T, Carranza H, Vargas C, Rosell R, Arrieta O. Cardona AF, et al. Among authors: barron lz. JCO Precis Oncol. 2021 Nov;5:839-848. doi: 10.1200/PO.20.00404. JCO Precis Oncol. 2021. PMID: 34994616